Triple-negative breast cancer (TNBC), which lacks expression of estrogen receptor (ER), progesterone receptor (PR) and HER-2, is believed to have a relatively aggressive tumor biology [2]. This evidence concerns the gene PGR and triple-negative breast carcinoma.